Related Experiment Video
Updated: Jul 12, 2025
08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.2K
Matrix metalloproteinases in intestinal fibrosis.
Carin Biel1, Klaas Nico Faber2, Ruud A Bank3
1Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, the Netherlands.
Journal of Crohn'S & Colitis
|October 25, 2023
Summary
Intestinal fibrosis, a complication of inflammatory bowel disease, involves excessive extracellular matrix buildup. Matrix metalloproteinases (MMPs) play a complex role in this process, offering potential therapeutic targets.
Area of Science:
- Gastroenterology and Molecular Biology
Background:
- Intestinal fibrosis, a significant complication of inflammatory bowel disease (IBD), particularly Crohn's disease (CD), is currently untreatable except by surgery.
- Fibrosis is characterized by excessive extracellular matrix (ECM) accumulation due to activated fibroblasts and smooth muscle cells, stemming from an imbalance in ECM production and degradation.
Approach:
- This review examines the current literature on ECM remodeling by matrix metalloproteinases (MMPs) in intestinal fibrosis.
- It specifically investigates the roles of MMPs and their inhibitors (TIMPs) in the context of IBD and fibrosis development.
Key Points:
- MMP activity is generally increased in IBD patients, but paradoxically lower in CD patients compared to ulcerative colitis patients.
- The precise regulation and functions of MMPs in fibrosis remain incompletely understood.
- MMPs are crucial for ECM degradation, and their dysregulation contributes to fibrosis.
Conclusions:
- Matrix metalloproteinases (MMPs) are implicated in the pathogenesis of intestinal fibrosis in inflammatory bowel disease.
- Further research into MMPs could identify novel biomarkers for disease progression and potential therapeutic targets for treating intestinal fibrosis.
